Ion Channel Gene Expression in Lung Adenocarcinoma: Potential Role in Prognosis and Diagnosis
暂无分享,去创建一个
Tong Zhou | Jae-Hong Ko | Wanjun Gu | W. Gu | Eun-A Ko | Jae-Hong Ko | I. Lim | H. Bang | Inja Lim | Hyoweon Bang | Tong Zhou | Eun A. Ko
[1] G. Santoni,et al. TRPV channels in tumor growth and progression. , 2011, Advances in experimental medicine and biology.
[2] J. Minna,et al. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[3] Luc Girard,et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. , 2007, Cancer research.
[4] L. Jan,et al. Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] Chuhsing Kate Hsiao,et al. Identification of a Novel Biomarker, SEMA5A, for Non–Small Cell Lung Carcinoma in Nonsmoking Women , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[6] Juan Zhou,et al. Endothelin-1 enhances proliferation of lung cancer cells by increasing intracellular free Ca2+. , 2008, Life sciences.
[7] G. Barritt,et al. TRP channels in cancer. , 2007, Biochimica et biophysica acta.
[8] K. Kunzelmann. Ion Channels and Cancer , 2005, The Journal of Membrane Biology.
[9] L. Holmberg,et al. Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] D. Khaitan,et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain , 2009, BMC Cancer.
[11] A. Jemal,et al. Global Cancer Statistics , 2011 .
[12] E. Wieben,et al. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. , 1992, Mayo Clinic proceedings.
[13] H. Sevestre,et al. Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status. , 2010, Histology and histopathology.
[14] N. Girard,et al. New driver mutations in non-small-cell lung cancer. , 2011, The Lancet. Oncology.
[15] F. Wrba,et al. The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. , 2000, The American journal of pathology.
[16] Y. Gruel,et al. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. , 2007, The international journal of biochemistry & cell biology.
[17] Jaime Prilusky,et al. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support , 1998, Bioinform..
[18] J. A. Peters,et al. Transient receptor potential cation channels in disease. , 2007, Physiological reviews.
[19] Nam Huh,et al. Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression , 2008, Clinical Cancer Research.
[20] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[21] Mansoor Abdul,et al. Activity of potassium channel-blockers in breast cancer. , 2003, Anticancer research.
[22] David Venet,et al. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..
[23] G. Santoni,et al. Expression of transient receptor potential vanilloid‐1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters , 2010, Histopathology.
[24] P. Dasgupta,et al. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. , 2008, Trends in pharmacological sciences.
[25] L. Ricci-Vitiani,et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. , 2010, Carcinogenesis.
[26] O. Crociani,et al. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.
[27] A. G. Cooper,et al. Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. , 2001, Cancer research.
[28] Charles Y. Lin,et al. Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.
[29] V. Firlej,et al. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. , 2010, Cancer research.
[30] T. Jentsch,et al. Ion channels: Function unravelled by dysfunction , 2004, Nature Cell Biology.
[31] D. Lancet,et al. GeneCards: integrating information about genes, proteins and diseases. , 1997, Trends in genetics : TIG.
[32] R. Kurzrock,et al. Targeted therapy in non-small-cell lung cancer—is it becoming a reality? , 2011, Nature Reviews Clinical Oncology.
[33] G. Santoni,et al. TRP channels and cancer: new targets for diagnosis and chemotherapy. , 2011, Endocrine, metabolic & immune disorders drug targets.
[34] D. Green,et al. c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.
[35] R. Sikes,et al. Voltage-sensitive ion channels and cancer , 2006, Cancer and Metastasis Reviews.
[36] M. Wigler,et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. , 2003, Cancer cell.
[37] Puthen V. Jithesh,et al. Gene Expression Meta-Analysis Identifies VDAC1 as a Predictor of Poor Outcome in Early Stage Non-Small Cell Lung Cancer , 2011, PloS one.
[38] Satoru Miyano,et al. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. , 2012, Cancer research.
[39] H. Schuller. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.
[40] S. Wacholder,et al. Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.
[41] S. Scheuring,et al. Supramolecular assembly of VDAC in native mitochondrial outer membranes. , 2007, Journal of molecular biology.
[42] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[43] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[44] C. Stock,et al. Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. , 2013, Cancer research.
[45] N. Prevarskaya,et al. Oncogenic TRP channels. , 2011, Advances in experimental medicine and biology.
[46] T. Bíró,et al. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.
[47] N. Prevarskaya,et al. Ion channels and the hallmarks of cancer. , 2010, Trends in molecular medicine.